Cryo-Cell International Inc (CCEL)
8.90
-0.10
(-1.11%)
USD |
NYAM |
May 10, 16:00
9.00
+0.10
(+1.12%)
After-Hours: 20:00
Cryo-Cell International Enterprise Value: 81.68M for May 10, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 10, 2024 | 81.68M |
May 09, 2024 | 82.49M |
May 08, 2024 | 80.39M |
May 07, 2024 | 79.50M |
May 06, 2024 | 79.50M |
May 03, 2024 | 81.93M |
May 02, 2024 | 79.01M |
May 01, 2024 | 76.74M |
April 30, 2024 | 76.90M |
April 29, 2024 | 77.55M |
April 26, 2024 | 78.04M |
April 25, 2024 | 72.77M |
April 24, 2024 | 73.34M |
April 23, 2024 | 72.12M |
April 22, 2024 | 73.74M |
April 19, 2024 | 70.34M |
April 18, 2024 | 69.28M |
April 17, 2024 | 64.26M |
April 16, 2024 | 63.85M |
April 15, 2024 | 66.93M |
April 12, 2024 | 69.07M |
April 11, 2024 | 69.59M |
April 10, 2024 | 71.14M |
April 09, 2024 | 70.68M |
April 08, 2024 | 71.47M |
Date | Value |
---|---|
April 05, 2024 | 70.89M |
April 04, 2024 | 70.23M |
April 03, 2024 | 71.96M |
April 02, 2024 | 71.38M |
April 01, 2024 | 71.15M |
March 28, 2024 | 71.14M |
March 27, 2024 | 75.59M |
March 26, 2024 | 75.92M |
March 25, 2024 | 66.51M |
March 22, 2024 | 62.47M |
March 21, 2024 | 59.41M |
March 20, 2024 | 59.74M |
March 19, 2024 | 57.93M |
March 18, 2024 | 57.35M |
March 15, 2024 | 56.19M |
March 14, 2024 | 55.62M |
March 13, 2024 | 58.67M |
March 12, 2024 | 55.12M |
March 11, 2024 | 56.36M |
March 08, 2024 | 59.50M |
March 07, 2024 | 59.91M |
March 06, 2024 | 55.04M |
March 05, 2024 | 56.19M |
March 04, 2024 | 53.47M |
March 01, 2024 | 50.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
33.34M
Minimum
Mar 28 2023
115.67M
Maximum
Sep 02 2021
60.36M
Average
57.76M
Median
Sep 04 2020
Enterprise Value Benchmarks
American Shared Hospital Services | 28.79M |
Novo Integrated Sciences Inc | 13.40M |
Astrana Health Inc | 1.618B |
P3 Health Partners Inc | 443.71M |
Biote Corp | 244.87M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 0.5562M |
Revenue (Quarterly) | 7.852M |
Total Expenses (Quarterly) | 7.036M |
EPS Diluted (Quarterly) | 0.0674 |
Gross Profit Margin (Quarterly) | 72.49% |
Profit Margin (Quarterly) | 7.08% |
Earnings Yield | -13.06% |
Operating Earnings Yield | 3.77% |
Normalized Earnings Yield | 1.691 |